Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:12 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 506285 | NSE: BAYERCROP

Bayer CropScience Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹3,629.51Overvalued by 23.49%vs CMP ₹4,744.00

P/E (31.8) × ROE (20.0%) × BV (₹695.00) × DY (2.64%)

₹1,925.88Overvalued by 59.40%vs CMP ₹4,744.00
MoS: -146.3% (Negative)Confidence: 70/100 (High)Models: All 10: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹3,657.3520%Over (-22.9%)
Graham NumberEarnings₹1,527.3014%Over (-67.8%)
Earnings PowerEarnings₹1,302.0012%Over (-72.6%)
DCFCash Flow₹1,668.9612%Over (-64.8%)
Net Asset ValueAssets₹695.206%Over (-85.3%)
EV/EBITDAEnterprise₹2,049.558%Over (-56.8%)
Dividend DiscountDividends₹1,031.608%Over (-78.3%)
Earnings YieldEarnings₹1,491.706%Over (-68.6%)
ROCE CapitalReturns₹1,797.748%Over (-62.1%)
Revenue MultipleRevenue₹1,826.905%Over (-61.5%)
Consensus (10 models)₹1,925.88100%Overvalued
Key Drivers: Wide model spread (₹695–₹3,657) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 0.8%

*Investments are subject to market risks

Investment Snapshot

73
Bayer CropScience Ltd scores 73/100 (Strong)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health92/100 · Strong
ROCE 24.8% ExcellentROE 20.0% ExcellentD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money60/100 · Moderate
FII holding up 0.35% (6mo) Slight increasePromoter holding at 71.4% Stable
Earnings Quality50/100 · Moderate
OPM stable around 16% Steady
Quarterly Momentum90/100 · Strong
Revenue (4Q): +8% YoY GrowingProfit (4Q): +29% YoY StrongOPM: 11.0% (up 9.0% YoY) Margin expansion
Industry Rank60/100 · Moderate
P/E 31.8 vs industry 25.3 In-lineROCE 24.8% vs industry 15.2% Above peers3Y sales CAGR: 5% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:12 am

Market Cap 21,318 Cr.
Current Price 4,744
Intrinsic Value₹1,925.88
High / Low 6,540/4,273
Stock P/E31.8
Book Value 695
Dividend Yield2.64 %
ROCE24.8 %
ROE20.0 %
Face Value 10.0
PEG Ratio41.47

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Bayer CropScience Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Bayer CropScience Ltd 21,318 Cr. 4,744 6,540/4,27331.8 6952.64 %24.8 %20.0 % 10.0
Sumitomo Chemical India Ltd 18,978 Cr. 380 665/36335.0 64.00.32 %25.1 %18.8 % 10.0
Atul Ltd 18,950 Cr. 6,436 7,793/4,75231.9 2,0100.39 %12.8 %9.10 % 10.0
Sharda Cropchem Ltd 8,026 Cr. 890 1,298/44014.2 2971.01 %16.5 %12.6 % 10.0
Rallis India Ltd 4,540 Cr. 233 386/19724.7 1061.07 %10.1 %6.65 % 1.00
Industry Average9,472.25 Cr1,009.7725.27369.000.53%15.21%19.87%6.67

All Competitor Stocks of Bayer CropScience Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 1,0389821,7401,6179557921,6311,7381,0571,0461,9151,5531,106
Expenses 9527771,3151,3128276951,3171,5541,0378761,5661,348989
Operating Profit 852064253051289731418420171348205117
OPM % 8%21%24%19%13%12%19%11%2%16%18%13%11%
Other Income 116242116152927243237191416
Interest 3784354346545
Depreciation 14273112151622141534271415
Profit before tax 18419540630612410531619034168335200113
Tax % 27%19%19%27%25%9%20%28%-2%15%17%24%15%
Net Profit 13415832822393962541363414327915396
EPS in Rs 29.9335.2773.0949.6020.7221.3656.5630.337.6131.8962.0133.9821.29

Last Updated: March 3, 2026, 11:54 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 12:40 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 3,1883,6602,7692,8032,7103,1673,6094,2614,7345,1405,1065,4735,621
Expenses 2,7683,1442,3342,3892,3002,6842,8833,4503,9234,2164,1474,7834,779
Operating Profit 419516435414410483726812812924959691842
OPM % 13%14%16%15%15%15%20%19%17%18%19%13%15%
Other Income 918882703951-64691121687611886
Interest 55107111014131322201720
Depreciation 65252529334465746480748591
Profit before tax 441574482448404480583794847990941707816
Tax % 34%33%35%35%26%30%19%38%24%23%21%20%
Net Profit 290383315291300337474493645758740568670
EPS in Rs 79.06104.5989.1382.3187.4198.18105.58109.72143.58168.71164.77126.38149.17
Dividend Payout % 7%20%19%21%21%18%24%105%104%77%85%99%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)32.07%-17.75%-7.62%3.09%12.33%40.65%4.01%30.83%17.52%-2.37%-23.24%
Change in YoY Net Profit Growth (%)0.00%-49.82%10.14%10.71%9.24%28.32%-36.64%26.82%-13.31%-19.89%-20.87%

Bayer CropScience Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:4%
5 Years:9%
3 Years:5%
TTM:15%
Compounded Profit Growth
10 Years:4%
5 Years:0%
3 Years:-2%
TTM:-11%
Stock Price CAGR
10 Years:3%
5 Years:-3%
3 Years:-1%
1 Year:-21%
Return on Equity
10 Years:21%
5 Years:23%
3 Years:24%
Last Year:20%

Last Updated: September 5, 2025, 2:36 pm

Balance Sheet

Last Updated: December 4, 2025, 2:30 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 37373535343445454545454545
Reserves 1,7061,9961,8042,0211,7442,2052,5282,5052,4792,6672,8042,8063,079
Borrowings 000000226867447105102
Other Liabilities 6457405977697561,3101,2621,6631,7421,8931,7012,2901,966
Total Liabilities 2,3872,7732,4372,8252,5353,5493,8364,2394,3534,6794,5975,2465,191
Fixed Assets 228322290342334440468425468462414470585
CWIP 2171172436475676981091191199
Investments 42968500041523841543541
Other Assets 1,9392,4222,0622,4102,1643,0623,2703,6863,7494,0664,0104,6224,557
Total Assets 2,3872,7732,4372,8252,5353,5493,8364,2394,3534,6794,5975,2465,191

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 282200206157121433666687216609952262
Cash from Investing Activity + -29048516-838-113-2976483086
Cash from Financing Activity + -480-42-590-73-581-158-148-556-703-613-656-619
Net Cash Flow -488644-36776-421162489138-42479296-272
Free Cash Flow 12229717010880378638656168537912222
CFO/OP 105%76%86%74%53%132%110%105%59%92%113%61%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow419.00516.00435.00414.00410.00483.00724.00786.00726.00850.00912.00586.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 475753728981736577696963
Inventory Days 9885169178175294206226235268222319
Days Payable 514052676716410114212712987148
Cash Conversion Cycle 94102171184197211177149185208204234
Working Capital Days 885392104134116776184867888
ROCE %24%31%25%23%22%25%30%31%31%34%34%25%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 71.44%71.44%71.44%71.44%71.44%71.44%71.44%71.44%71.44%71.44%71.44%71.44%
FIIs 3.18%3.18%3.30%3.53%3.62%3.63%3.30%3.42%3.49%3.64%3.80%3.84%
DIIs 12.74%13.06%13.23%12.70%12.80%12.47%12.08%11.69%11.56%11.38%11.22%11.47%
Public 12.64%12.32%12.05%12.33%12.15%12.47%13.18%13.45%13.53%13.55%13.56%13.27%
No. of Shareholders 57,25348,40445,32946,90745,85246,20151,28954,28954,21655,75358,10958,571

Shareholding Pattern Chart

No. of Shareholders

Bayer CropScience Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Quant Small Cap Fund 1,037,211 1.75 484.63986,3942025-12-15 03:03:085.15%
Nippon India Small Cap Fund 560,144 0.39 261.72559,8982026-02-23 02:51:030.04%
Aditya Birla Sun Life Large Cap Fund 349,249 0.54 163.18336,8082026-01-26 05:24:403.69%
Nippon India Growth Mid Cap Fund 303,512 0.32 141.81N/AN/AN/A
Aditya Birla Sun Life MNC Fund 230,758 3.14 107.82N/AN/AN/A
DSP Small Cap Fund 218,421 0.6 102.06205,4602026-03-10 02:15:586.31%
Bandhan ELSS Tax Saver Fund 177,500 1.18 82.94175,0002026-02-23 02:51:031.43%
Bandhan Value Fund 160,000 0.74 74.76155,0002026-02-23 02:51:033.23%
Tata India Pharma & HealthCare Fund 92,824 3.33 43.37N/AN/AN/A
Bandhan Flexi Cap Fund 85,000 0.53 39.7280,0002026-01-25 04:19:526.25%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 126.38164.77168.71143.58109.72
Diluted EPS (Rs.) 126.38164.77168.71143.58109.72
Cash EPS (Rs.) 145.41181.40186.57158.08126.19
Book Value[Excl.RevalReserv]/Share (Rs.) 634.83634.61604.03562.20568.00
Book Value[Incl.RevalReserv]/Share (Rs.) 634.83634.61604.03562.20568.00
Dividend / Share (Rs.) 125.00140.00130.00150.00115.00
Revenue From Operations / Share (Rs.) 1219.021136.571144.701054.43949.06
PBDIT / Share (Rs.) 180.24230.51220.07192.81194.99
PBIT / Share (Rs.) 161.34214.03202.36178.44178.62
PBT / Share (Rs.) 157.55209.66220.51188.60176.95
Net Profit / Share (Rs.) 126.50164.92168.86143.72109.82
PBDIT Margin (%) 14.7820.2819.2218.2820.54
PBIT Margin (%) 13.2318.8317.6716.9218.82
PBT Margin (%) 12.9218.4419.2617.8818.64
Net Profit Margin (%) 10.3714.5114.7513.6311.57
Return on Networth / Equity (%) 19.9225.9827.9525.5619.33
Return on Capital Employeed (%) 23.9632.0331.3129.7430.05
Return On Assets (%) 10.8216.1016.2014.8211.63
Asset Turnover Ratio (%) 1.111.101.141.101.06
Current Ratio (X) 2.012.442.192.152.26
Quick Ratio (X) 0.941.481.181.241.41
Inventory Turnover Ratio (X) 2.801.481.391.822.17
Dividend Payout Ratio (NP) (%) 98.9081.9374.09104.47104.82
Dividend Payout Ratio (CP) (%) 86.0474.4867.0694.9891.22
Earning Retention Ratio (%) 1.1018.0725.91-4.47-4.82
Cash Earning Retention Ratio (%) 13.9625.5232.945.028.78
Interest Coverage Ratio (X) 47.6152.8144.3167.1169.48
Interest Coverage Ratio (Post Tax) (X) 34.4138.7830.3546.4939.73
Enterprise Value (Cr.) 21230.1022377.2917307.3021584.0322612.20
EV / Net Operating Revenue (X) 3.884.383.374.565.31
EV / EBITDA (X) 26.2321.6217.5224.9325.83
MarketCap / Net Operating Revenue (X) 4.044.613.544.735.59
Retention Ratios (%) 1.0918.0625.90-4.47-4.82
Price / BV (X) 7.768.266.708.869.34
Price / Net Operating Revenue (X) 4.044.613.544.735.59
EarningsYield 0.020.030.040.020.02

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Bayer Cropscience Ltd. is a Public Limited Listed company incorporated on 09/09/1958 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24210MH1958PLC011173 and registration number is 011173. Currently Company is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company's Total Operating Revenue is Rs. 5473.40 Cr. and Equity Capital is Rs. 44.90 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Agro Chemicals/PesticidesBayer House, Central Avenue, Mumbai Maharashtra 400607Contact not found
Management
NamePosition Held
Mr. Pankaj Ramanbhai PatelChairman & Ind.Dire (Non-Exe)
Mr. Simon Thorsten WiebuschVice Chairman & Mng.Director
Mr. Vinit Rajesh JindalExecutive Director & CFO
Dr. Thomas HoffmannNon Exe.Non Ind.Director
Ms. Jana Marlen AckermannNon Exe.Non Ind.Director
Ms. Radhika RajanInd. Non-Executive Director
Mr. Sekhar NatarajanInd. Non-Executive Director
Mr. Sanjiv RangrassInd. Non-Executive Director

FAQ

What is the intrinsic value of Bayer CropScience Ltd and is it undervalued?

As of 15 April 2026, Bayer CropScience Ltd's intrinsic value is ₹1925.88, which is 59.40% lower than the current market price of ₹4,744.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (20.0 %), book value (₹695), dividend yield (2.64 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Bayer CropScience Ltd?

Bayer CropScience Ltd is trading at ₹4,744.00 as of 15 April 2026, with a FY2026-2027 high of ₹6,540 and low of ₹4,273. The stock is currently near its 52-week low. Market cap stands at ₹21,318 Cr..

How does Bayer CropScience Ltd's P/E ratio compare to its industry?

Bayer CropScience Ltd has a P/E ratio of 31.8, which is above the industry average of 25.27. The premium over industry average may reflect growth expectations or speculative interest.

Is Bayer CropScience Ltd financially healthy?

Key indicators for Bayer CropScience Ltd: ROCE of 24.8 % indicates efficient capital utilization; ROE of 20.0 % shows strong shareholder returns. Dividend yield is 2.64 %.

Is Bayer CropScience Ltd profitable and how is the profit trend?

Bayer CropScience Ltd reported a net profit of ₹568 Cr in Mar 2025 on revenue of ₹5,473 Cr. Compared to ₹645 Cr in Mar 2022, the net profit shows a declining trend.

Does Bayer CropScience Ltd pay dividends?

Bayer CropScience Ltd has a dividend yield of 2.64 % at the current price of ₹4,744.00. This is a relatively attractive yield for income-seeking investors.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Bayer CropScience Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports